BMRN

BioMarin Pharmaceutical Inc.NASDAQHealthcare

$55.50-3.04%OpenMarket Cap: $10.67B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	B of A Securities	—	Buy	—
2026-03-04	Barclays	—	Overweight	—
2026-03-02	HC Wainwright & Co.	—	Neutral	—
2026-03-02	Freedom Broker	—	Buy	—
2026-02-26	Canaccord Genuity	—	Buy	—
2026-02-25	Bernstein	—	Outperform	—
2026-02-25	Guggenheim	—	Buy	—
2026-02-24	Oppenheimer	—	Outperform	—
2026-02-18	Wells Fargo	—	Overweight	—
2026-02-06	Piper Sandler	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$5.37	$4.03B	8
Sun Dec 31	$6.76	$4.42B	8
Mon Dec 31	$7.57	$4.79B	6
Tue Dec 31	$8.40	$5.08B	6